Irma Gaillard's Colleagues at Amprion
Irma Gaillard's Contact Details
N/A
Amprion
Irma Gaillard's Company Details
๐๐ฟ๐ผ๐๐ป๐ฑ๐ฏ๐ฟ๐ฒ๐ฎ๐ธ๐ถ๐ป๐ด ๐๐ฒ๐๐๐ถ๐ป๐ด ๐ณ๐ผ๐ฟ ๐๐น๐๐ต๐ฒ๐ถ๐บ๐ฒ๐ฟ'๐, ๐ฃ๐ฎ๐ฟ๐ธ๐ถ๐ป๐๐ผ๐ป'๐, ๐ฎ๐ป๐ฑ ๐๐ฒ๐๐ ๐๐ผ๐ฑ๐ ๐๐ฒ๐บ๐ฒ๐ป๐๐ถ๐ฎ. ๐ช๐ฒ ๐๐ฟ๐ฎ๐ฐ๐ธ ๐๐ต๐ฒ ๐ฝ๐ฟ๐ถ๐ผ๐ป ๐ฏ๐ถ๐ผ๐บ๐ฎ๐ฟ๐ธ๐ฒ๐ฟ๐ ๐ฑ๐ฟ๐ถ๐๐ถ๐ป๐ด ๐๐ต๐ฒ๐๐ฒ ๐ฏ๐ฟ๐ฎ๐ถ๐ป ๐ฑ๐ถ๐๐ฒ๐ฎ๐๐ฒ๐.Amprion pioneers Prion Early Detection Testingโ for Alzheimer's and Parkinson's. For the first time in history, our proprietary molecular-based diagnostic technology tracks the biomarkers, aka prions including Abeta, Tau and Synuclein, that drive Alzheimer's and Parkinson's prior to any clinical symptoms. Currently awarded FDA Breakthrough Device Designation for the detection of misfolded Synuclein, a biomarker for Parkinson's, the company is also applying the same assay to detect misfolded Abeta and Tau, which are known to cause Alzheimer's.Amprion expects to obtain FDA approvals in the next 18 months and to launch various early detection testing for Alzheimer's and Parkinson's accordingly. Early diagnosis of Alzheimer's and Parkinson's empowers us to find a cure to stop these diseases on their tracks. Learn more about ParkinZheimerโour philosophy and a pillar of our scientific discoveryโAlzheimer's and Parkinson's are two related diseases on a spectrum: https://www.amprionme.com/our-philosophy/Join us in the fight for brain health. Sign up for email alerts on our latest breakthroughs: https://www.amprionme.com/join-the-fight/== About FDA Breakthrough Device Designation ===FDA's Breakthrough Devices Program is designed to speed up development, assessment and review of medical devices that provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. == How Amprion Works ===Amprion's breakthrough early testing for Alzheimer's and Parkinson's tracks the prion biomarkers, using spinal fluid (CSF) and/or blood. Learn more at https://AmprionMe.com. Join the Fight For Brain Health #BrainHealth